Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients

Table 3

MICs of antibiotics for MBL-producing P.  aeruginosa isolates.

Isolates number	MICs (𝜇g/mL)
	PM	PTc	TZ	TZL	CI	AK	GM	IP	CT
	≥32	≥128/4	≥128/2	≥32	≥4	≥64	≥4	≥16	≥32
1	≥256	16	≥256	≥256	2	12	3	≥32	≥256
2	12	64	8	3	≥32	16	≥256	≥32	≥256
3	8	64	64	24	≥32	≥256	12	≥32	≥256
4	4	3	6	2	≥32	≥256	≥256	≥32	32
5	4	3	6	1.5	≥32	≥256	≥256	≥32	32
6	64	≥256	≥256	≥256	≥32	≥256	≥256	≥32	≥256
7	24	≥256	≥256	192	≥32	≥256	12	≥32	≥256
8	6	96	96	24	0.094	4	2	≥32	≥256
9	≥256	3	≥256	≥256	≥32	32	12	≥32	≥256
10	≥256	2	4	1.5	≥32	2	2	≥32	16
11	≥256	≥256	≥256	≥256	≥32	≥256	32	≥32	≥256
12	6	24	8	16	≥32	≥256	1.5	≥32	≥256
13	≥256	≥256	≥256	≥256	≥32	≥256	≥256	≥32	≥256
14	≥256	24	≥256	≥256	1	6	2	≥32	≥256
15	16	24	16	4	≥32	12	≥256	≥32	≥256
16	≥256	≥256	48	8	≥32	96	≥256	≥32	≥256
17	6	12	12	2	≥32	6	≥256	≥32	≥256
18	≥256	4	≥256	≥256	≥32	96	32	≥32	≥256
19	64	≥256	≥256	96	0.094	96	32	≥32	≥256
20	8	32	12	2	≥32	16	≥256	≥32	≥256
21	16	16	24	4	≥32	48	≥256	≥32	≥256
22	256	≥256	≥256	≥256	≥32	128	32	≥32	≥256
23	≥256	≥256	≥56	256	≥32	≥256	32	≥32	≥256
24	8	12	≥256	4	0.064	8	≥256	≥32	≥256
25	≥256	≥256	≥256	128	≥32	48	32	≥32	≥256
26	≥256	≥256	≥256	≥256	≥32	≥256	≥256	≥32	≥256
27	16	≥256	≥256	32	0.064	8	32	≥32	≥256
28	64	≥256	≥256	≥256	0.064	32	32	≥32	≥256
29	2	4	12	2	0.125	4	2	≥32	≥256
30	2	4	8	1.5	0.125	4	2	≥32	≥256
31	8	128	6	24	0.094	6	2	≥32	≥256
32	12	32	2	8	0.064	6	2	≥32	≥256
33	6	≥256	8	3	≥32	128	2	≥32	≥256

PM: cefepime, PTc: piperacillin/tazobactam, TZL: ceftazidime/clavulanic acid, TZ: Ceftazidime, CI: ciprofloxacin, AK: Amikacin, GM: Gentamicin, IP: Imipenem, CT: Cefotaxime.